Evidence map›Paper›PMID 35704335›Full record

ArticleClinical & experimental ophthalmology2022

Survey of intravitreal injection outcomes amongst ophthalmologists using pre-filled aflibercept syringes.

Daniel J Lee, Brittni A Scruggs, Ambar Faridi, Erik Sánchez, Merina Thomas

Open access · greenAbstract readLetter
In one paragraph

Article in Clinical & experimental ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Reply.Ophthalmology science · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Daniel J LeeCasey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0003-0429-7713
Brittni A ScruggsCasey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon, USA.
Ambar FaridiCasey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon, USA.
Erik SánchezDepartment of Physics, Portland State University, Portland, Oregon, USA.
Merina ThomasCasey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon, USA.
Oregon Health & Science University · USPortland State University · US

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Kate E Keller · 1995 to 2026
$19.4M
NEI NIH HHS P30 EY010572
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

OphthalmologistsAngiogenesis InhibitorsHumansIntravitreal InjectionsRanibizumabReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsSyringesafliberceptAngiogenesis InhibitorsRanibizumabReceptors, Vascular Endothelial Growth FactorRecombinant Fusion Proteins

Identifiers

PMID35704335
PMCPMC9588531
OpenAlexW4282971158

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.